Activation of MMPs, especially the gelatinases MMP-2 and MMP-9, is associated with adverse remodeling and LV dilatation in heart failure patients, and precedes LV dysfunction in animal models with tachycardiomyopathy, suggesting that they are early markers of cardiomyopathy [34]. This evidence concerns the gene MMP9 and heart failure.